Portage Biotech (PRTG) Competitors $6.19 +0.07 (+1.14%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$6.00 -0.19 (-3.09%) As of 07/11/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTG vs. CARA, TENX, CYTH, CALC, BCAB, GBIO, FBLG, FGEN, NNVC, and ELEVShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include Cara Therapeutics (CARA), Tenax Therapeutics (TENX), Cyclo Therapeutics (CYTH), CalciMedica (CALC), BioAtla (BCAB), Generation Bio (GBIO), FibroBiologics (FBLG), FibroGen (FGEN), NanoViricides (NNVC), and Elevation Oncology (ELEV). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Its Competitors Cara Therapeutics Tenax Therapeutics Cyclo Therapeutics CalciMedica BioAtla Generation Bio FibroBiologics FibroGen NanoViricides Elevation Oncology Portage Biotech (NASDAQ:PRTG) and Cara Therapeutics (NASDAQ:CARA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings. Which has more risk and volatility, PRTG or CARA? Portage Biotech has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Cara Therapeutics has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Is PRTG or CARA more profitable? Portage Biotech has a net margin of 0.00% compared to Cara Therapeutics' net margin of -1,099.76%. Portage Biotech's return on equity of 0.00% beat Cara Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Portage BiotechN/A N/A N/A Cara Therapeutics -1,099.76%-367.97%-107.43% Do insiders & institutionals hold more shares of PRTG or CARA? 13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 44.7% of Cara Therapeutics shares are owned by institutional investors. 3.1% of Cara Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better earnings & valuation, PRTG or CARA? Portage Biotech has higher earnings, but lower revenue than Cara Therapeutics. Portage Biotech is trading at a lower price-to-earnings ratio than Cara Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPortage BiotechN/AN/A-$75.34M-$41.65-0.15Cara Therapeutics$7.14M0.00-$118.51M-$21.01N/A Does the media favor PRTG or CARA? In the previous week, Portage Biotech had 1 more articles in the media than Cara Therapeutics. MarketBeat recorded 1 mentions for Portage Biotech and 0 mentions for Cara Therapeutics. Portage Biotech's average media sentiment score of 1.87 beat Cara Therapeutics' score of 0.00 indicating that Portage Biotech is being referred to more favorably in the media. Company Overall Sentiment Portage Biotech Very Positive Cara Therapeutics Neutral SummaryPortage Biotech beats Cara Therapeutics on 7 of the 12 factors compared between the two stocks. Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.50M$2.93B$5.54B$9.08BDividend YieldN/A2.43%5.06%4.03%P/E Ratio-0.1520.9928.2820.33Price / SalesN/A251.49411.8596.42Price / Cash0.7641.0526.2427.98Price / Book1.667.638.125.50Net Income-$75.34M-$55.05M$3.19B$250.38M7 Day Performance9.95%7.11%3.68%2.19%1 Month Performance3.34%8.14%7.69%10.92%1 Year Performance72.91%1.62%29.35%16.41% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage Biotech0.2478 of 5 stars$6.19+1.1%N/A+72.9%$6.50MN/A-0.156Positive NewsCARACara Therapeutics0.2207 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeTENXTenax Therapeutics1.6634 of 5 stars$5.80+0.9%$17.50+201.7%+74.5%$24.06MN/A-2.349Positive NewsGap UpCYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809CALCCalciMedica2.9123 of 5 stars$1.64+1.6%$18.00+1,000.2%-59.1%$22.98MN/A-1.0530Gap UpBCABBioAtla2.2141 of 5 stars$0.39+1.8%$5.00+1,172.3%-78.7%$22.96M$11M-0.3260GBIOGeneration Bio3.8664 of 5 stars$0.34+3.6%$7.33+2,044.2%-85.8%$22.93M$19.89M-0.32150FBLGFibroBiologics3.5432 of 5 stars$0.59-1.8%$13.00+2,088.6%-86.7%$22.73MN/A-2.8310Gap UpFGENFibroGen4.7334 of 5 stars$5.58+3.9%$250.00+4,380.3%-72.5%$22.54M$29.62M-2.23570Positive NewsNNVCNanoViricides0.3113 of 5 stars$1.39+0.7%N/A-19.8%$22.34MN/A-1.9320Positive NewsELEVElevation Oncology2.8482 of 5 stars$0.38-0.8%$3.39+800.5%-86.9%$22.27MN/A-0.4640 Related Companies and Tools Related Companies Cara Therapeutics Alternatives Tenax Therapeutics Alternatives Cyclo Therapeutics Alternatives CalciMedica Alternatives BioAtla Alternatives Generation Bio Alternatives FibroBiologics Alternatives FibroGen Alternatives NanoViricides Alternatives Elevation Oncology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTG) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTG Stock Alerts